Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Posner

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Hybridoma|April 1, 1989
The generation of hybridomas secreting human monoclonal antibodies reactive with type II collagenM R Posner, H J Barrach, H S Elboim, et al.
Diseases of the Colon and Rectum|July 1, 1997
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trialP M Sanz-Altamira, L D Spence, M S Huberman, et al.
Cancer|January 1, 1987
A phase I trial of continuous infusion cisplatinM R Posner, L Ferrari, J F Belliveau, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patientsJ Kan-Mitchell, P E Liggett, W Harel, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner, J H Lorch, O Goloubeva, et al.
Virology|August 1, 1994
Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitroP P Jagodzinski, R Wiaderkiewicz, G Kurzawski, et al.
Oral Oncology|March 9, 2019
Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostainingF El-Salem, M Mansour, M Gitman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 18, 2000
Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2S Cataltepe, C Schick, C J Luke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol useC S Furniss, M D McClean, J F Smith, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Hybridoma|April 1, 1989
The generation of hybridomas secreting human monoclonal antibodies reactive with type II collagenM R Posner, H J Barrach, H S Elboim, et al.
Diseases of the Colon and Rectum|July 1, 1997
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trialP M Sanz-Altamira, L D Spence, M S Huberman, et al.
Cancer|January 1, 1987
A phase I trial of continuous infusion cisplatinM R Posner, L Ferrari, J F Belliveau, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patientsJ Kan-Mitchell, P E Liggett, W Harel, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner, J H Lorch, O Goloubeva, et al.
Virology|August 1, 1994
Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitroP P Jagodzinski, R Wiaderkiewicz, G Kurzawski, et al.
Oral Oncology|March 9, 2019
Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostainingF El-Salem, M Mansour, M Gitman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 18, 2000
Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2S Cataltepe, C Schick, C J Luke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol useC S Furniss, M D McClean, J F Smith, et al.
Pageof 11